Evidence map›Paper›PMID 42873050›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Composition-Dependent Microwave Shielding Performance of Kaolinite/Chopped-Strand Composites for Wide Frequency Range.

Mehriban Emek

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mehriban EmekFaculty of Aviation and Space Sciences, Department of Aviation Management, Adana Alparslan Türkeş Science and Technology University, Adana 01250, Turkey.ORCID 0000-0001-7322-9808

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing demand for high-frequency electronic and communication systems has intensified the need for lightweight and efficient electromagnetic interference (EMI) shielding materials. In this study, the conventional oxide mixing method was used to form kaolinite-chopped strand composites. Natural kaolinite powder was calcined at 450 °C for 4 h to remove volatile and organic components before composite fabrication. Kaolinite/chopped-strand epoxy composites were fabricated and evaluated for their microwave shielding effectiveness in the 0-4.4 GHz frequency range. Composites with different kaolinite-to-chopped-strand weight ratios were prepared using a controlled mixing and molding process to obtain thin specimens with a uniform thickness of 1.4 mm. X-ray diffraction, scanning electron microscopy, and energy-dispersive X-ray spectroscopy were used primarily to characterize the kaolinite powder. Because composite-level mapping was not performed, the uniformity of filler dispersion is interpreted cautiously. Microwave shielding effectiveness was measured using a two-port vector network analyzer (VNA). The composite containing 80 wt.% kaolinite and 20 wt.% chopped strands showed the highest shielding performance, with a maximum total shielding effectiveness of 21.57 dB at 0.58 GHz. The observed shielding behavior is consistent with absorption-dominated attenuation supported by S-parameter-derived reflection, transmission, and absorption trends. This can arise from polarization losses and interfacial charge accumulation in heterogeneous dielectric composites. The results indicate that kaolinite/chopped-strand epoxy composites are low cost and sustainable materials for broadband microwave shielding applications.

Indexed as

chopped strandskaolinitematrix compositesmicrowave shielding effectmixed-oxide

Identifiers

PMID42873050
PMCPMC13667123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.